HAYWARD, Calif.--(BUSINESS WIRE)--
Impax Laboratories, Inc. (NASDAQ: IPXL) today announced
that the Company will present at the 31st Annual J.P. Morgan
Healthcare Conference on Monday, January 7, at 3:00 p.m. Pacific
Standard Time. The conference will be held at the Westin St. Francis
Hotel, San Francisco, CA.
Individuals may listen to the live or an archived presentation made at
the conference, which will be posted in the investor relations section
of the Company’s web site at www.impaxlabs.com.
This presentation will be archived on the Company’s web site for 30 days.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. (Impax) is a technology based specialty
pharmaceutical company applying its formulation expertise and drug
delivery technology to the development of controlled-release and
specialty generics in addition to the development of branded products.
Impax markets its generic products through its Global Pharmaceuticals
division and markets its branded products through the Impax
Pharmaceuticals division. Additionally, where strategically appropriate,
Impax has developed marketing partnerships to fully leverage its
technology platform. Impax is headquartered in Hayward, California, and
has a full range of capabilities in its Hayward, Philadelphia and Taiwan
facilities. For more information, please visit the Company's Web site
at: www.impaxlabs.com.
Source: Impax Laboratories, Inc.